Cargando…
Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program
Hepatitis C virus (HCV) is a significant public health problem that disproportionately afflicts people who inject drugs. We describe outcomes of HCV treatment co-located within a syringe services program (SSP). Fifty-three participants started therapy, and 91% achieved sustained virologic response....
Autores principales: | Eckhardt, Benjamin J, Scherer, Matthew, Winkelstein, Emily, Marks, Kristen, Edlin, Brian R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887278/ https://www.ncbi.nlm.nih.gov/pubmed/29644246 http://dx.doi.org/10.1093/ofid/ofy048 |
Ejemplares similares
-
917. Accessible HCV Care for People Who Inject Drugs: Randomized Clinical Trial Comparing Low-Threshold Treatment at a Syringe Service Program Versus Facilitated Referral
por: Eckhardt, Benjamin, et al.
Publicado: (2021) -
Hospital admissions among people who inject opioids following syringe services program implementation
por: Bornstein, K. J., et al.
Publicado: (2020) -
Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention
por: Eckhardt, Benjamin, et al.
Publicado: (2017) -
“Treated like a Human Being”: perspectives of people who inject drugs attending low-threshold HCV treatment at a syringe service program in New York City
por: Kapadia, Shashi N., et al.
Publicado: (2023) -
Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange Programs
por: Barocas, Joshua A., et al.
Publicado: (2016)